Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 152
Titolo Tipologia Data di pubblicazione Autori File
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 01 - Articolo su rivista 2023 Pagani, LisaChinello, CliziaRisca, GiuliaCapitoli, GiuliaCriscuolo, LucreziaPiga, IsabellaMuscatello, AntonioFavalli, AndreaGori, AndreaBandera, AlessandraMagni, Fulvio +
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 02 - Intervento a convegno 2023 Lisa PaganiPaolo PrevitaliClizia ChinelloGiulia CapitoliGiulia RiscaRenato Alberto SinicoBarbara TrezziAndrea LombardiAndrea GoriAlessandra BanderaCristina MeregalliGuido CavalettiFulvio Magni +
Direct quantification of cytosolic delivery of drug nanocarriers using FlAsH-EDT2 01 - Articolo su rivista 2023 Rotem, RBertolini, JASalvioni, LBarbieri, LRizzuto, MATinelli, VGori, AColombo, MProsperi, D +
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 01 - Articolo su rivista 2023 Bernasconi D.Squillace N.Muscatello A.Bandera A.Gori A. +
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 02 - Intervento a convegno 2022 Pagani, LChinello, CMahajneh, AClerici, FCriscuolo, LCapitoli, GRisca, GFavalli, ABandera, ALombardi, AMuscatello, AGori, AMagni, F +
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 02 - Intervento a convegno 2022 Pagani, LChinello, CMahajneh, AClerici, FPanarello, GFavalli, ABandera, AMuscatello, AGori, AMagni, F +
Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells 01 - Articolo su rivista 2022 Colombo M.Marongiu L.Mingozzi F.Marzi R.Cigni C.Facchini F. A.Rotem R.Valache M.Stucchi G.Rocca G.Gornati L.Rizzuto M. A.Salvioni L.Zanoni I.Gori A.Prosperi D.Granucci F.
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 01 - Articolo su rivista 2022 Pagani, LisaChinello, CliziaClerici, FrancescaFavalli, AndreaMuscatello, AntonioGori, AndreaMagni, Fulvio +
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 01 - Articolo su rivista 2022 Favalli A.Gobbini A.Marongiu L.Granucci F.Bandera A.Gori A. +
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy 01 - Articolo su rivista 2022 Corrao G.Franchi M.Leoni O.Gori A. +
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) 99 - Altro 2022 Gobbini A.Favalli A.Bandera A.Gori A. +
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 02 - Intervento a convegno 2021 Lisa PaganiClizia ChinelloAllia MahajnehFrancesca ClericiGaia PanarelloAndrea FavalliAlessandra BanderaAntonio MuscatelloAndrea GoriFulvio Magni +
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 01 - Articolo su rivista 2021 Soria A.Fagiuoli S.Bruno R.Gori A.Puoti M.Bonfanti P. +
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 01 - Articolo su rivista 2021 Puoti M.Bandera A.Bonfanti P.Gori A.Lapadula G. +
Combination antifungal therapy for invasive mold infections among pediatric patients with hematological malignancies: Data from a real-life case-series 01 - Articolo su rivista 2019 Longhi B.Migliorino G. M.Bandera A.Rizzari C.Gori A.Colombini A. +
Impact of orotracheal intubation and mechanical ventilation on the microbiota of the lung in the development of Ventilator- Associated Pneumonia 02 - Intervento a convegno 2019 R. PinciroliA. VargioluA. BanderaA. GoriG. Citerio +
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 01 - Articolo su rivista 2019 Puoti M.Gori A.Soria A.Strazzabosco M.Ciaccio A.Gemma M.Foti G. +
The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy 01 - Articolo su rivista 2019 Gori A.Lapadula G. +
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 01 - Articolo su rivista 2019 Bresciani E.Saletti C.Squillace N.Rizzi L.Molteni L.Meanti R.Gori A.Locatelli V.Torsello A. +
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 01 - Articolo su rivista 2019 Gori A.Migliorino G.Puoti M. +
Mostrati risultati da 1 a 20 di 152
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile